Newsmakers

Worksport (NASDAQ: WKSP) Posts Q2 2025 Results: Gross Profit Increases 173%, Revenue Jumps 83%, Margin Expands 870 bps, Operating Loss Improves 15% [QoQ].

Company Reaffirms ≥$20 Million 2025 Revenue Target and Highlights Clear Path to Near-Term Operational Cash Flow Positivity West Seneca, New York, Aug. 13, 2025  — Worksport Ltd. (NASDAQ: WKSP) (“Worksport” or the “Company”), a U.S. based […]

Newsmakers

Hoth Therapeutics’ (NASDAQ: HOTH) Cancer Therapeutic HT-KIT Surpasses Preclinical Milestones With Potent Anti-Tumor Activity and GLP-Validated Bioanalytical Results, Exceeding Regulatory Standards

NEW YORK, Sept. 2, 2025  — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical innovator, today announced combined positive findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT, including compelling anti-tumor efficacy, a clean […]

No Picture
Newsmakers

Aditxt’s (NASDAQ: ADTX) Subsidiary Adimune Highlights Its Approach to Reprogramming the Immune System Through DNA Instructions, Now with 96 Granted and 22 Pending Patents Targeting Autoimmunity Market Estimated at Over $160 Billion by 2030

Plans to seek FDA submission and approval for first-in-human trials in type 1 diabetes and stiff person syndrome targeted for early 2026 MOUNTAIN VIEW, Calif., August 25, 2025—-Aditxt, Inc. (NASDAQ: ADTX) (“Aditxt”, or the “Company”), […]

Newsmakers

Advent Technologies (NASDAQ: ADN) engages Fata Advisory to Support Business Development for Aerospace, Defense, and Commercial Markets

LIVERMORE, Calif., Aug. 27, 2025  — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven leader in fuel cells and hydrogen technologies, is pleased to announce that it has engaged Fata Advisory, LLC to support the […]

Healthcare

Wellgistics Health (NASDAQ: WGRX) Introduces HubRx AI: Advancing the AI-Powered Prescription Ecosystem

TAMPA, FL / August 27, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) (“Wellgistics Health” or the “Company”), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the introduction of HubRx AI – a fully […]

Aviation

Advent Technologies (NASDAQ: ADN) and Global Semiconductor & Wireless Technology Company Sign Agreement for Ion Pair Membrane Development for Gas Sensing Advent Technologies Holdings, Inc. Thu, August 21, 2025 at 5:00 AM PDT 4 min read

LIVERMORE, Calif., Aug. 21, 2025  — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation driven leader in the fuel cell and hydrogen technology space, has entered into an agreement with a U.S. based global leader […]

Aerospace & Defense

Advent Technologies (NASDAQ: ADN) and Stralis announce Pioneering Relationship to Advance Hydrogen Electric Flight

LIVERMORE, Calif., Aug. 18, 2025 — Advent Technologies Holdings, Inc. (NASDAQ: ADN) an innovation-driven leader in the fuel cell and hydrogen technology sector, is supplying its proprietary membrane electrode assembly technology to Stralis Aircraft, based […]

Aerospace & Defense

Advent Technologies (NASDAQ: ADN) Enhances License to Groundbreaking Ion Pair Technology Developed at Los Alamos National Laboratory by Acquiring Exclusivity in Marine, Aviation, and Portable Power Fields

LIVERMORE, Calif., Aug. 12, 2025  — Advent Technologies Holdings, Inc. (NASDAQ: ADN), an innovation-driven company in the fuel cell and hydrogen technology space, announced today that it has entered into a new enhanced license agreement […]

No Picture
Newsmakers

Aditxt’s (NASDAQ: ADTX) Subsidiary, Pearsanta, Inc. Engages Spartan Capital as Lead Underwriter for Planned IPO

Planned IPO Aligns with Aditxt’s Acquire, Build and Capitalize (ABC) Monetization Framework MOUNTAIN VIEW, Calif., July 29, 2025—-Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform dedicated to accelerating promising health innovations, […]

Newsmakers

Hoth Therapeutics (NASDAQ: HOTH) Announces Engagement with ICON and Expansion of Phase II Clinical Trial for HT-001 in Europe

The Company plans to extend its Phase II trial of HT-001 in Cancer Patients with skin toxicities in European Union (EU) Countries NEW YORK, July 29, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma […]

Newsmakers

Hoth Therapeutics (NASDAQ: HOTH) Signs VA Research Deal to Advance GDNF as Breakthrough Therapy for Obesity and Fatty Liver – Side-by-Side Study vs. Semaglutide Begins

NEW YORK, July 22, 2025 — Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharma innovator, today announced a CRADA (Cooperative Research and Development Agreement) with the U.S. Department of Veterans Affairs and Foundation for Atlanta Veterans […]

Newsmakers

Snow Lake (NASDAQ: LITM) Advances Uranium Projects in Wyoming and Namibia in Support of U.S. Policies on National & Energy Security

Winnipeg, Manitoba– – July 18, 2025 – Snow Lake Resources Ltd., d/b/a Snow Lake Energy (NASDAQ: LITM) (“Snow Lake“), a uranium exploration and development company, provides an update on progress at its uranium projects in […]

No Picture
Newsmakers

Aditxt (NASDAQ: ADTX) Unveils bitXbio™: A Bitcoin-Backed Treasury Strategy Designed to Accelerate Biotech Commercialization

Plan Combines Bitcoin Treasury Strategy and Equity Line to Support 2026 Potential Monetization Events, Starting with Pearsanta’s Planned IPO MOUNTAIN VIEW, Calif.—Aditxt, Inc. (Nasdaq: ADTX) (“Aditxt” or the “Company”), a social innovation platform accelerating promising health […]